The asthma drugs market is experiencing steady growth, driven by the rising prevalence of asthma, increasing air pollution, growing awareness about respiratory diseases, and advancements in targeted therapies. According to Business Market Insights, the market was valued at USD 24.85 billion in 2025 and is expected to reach USD 38.76 billion by 2033, registering a CAGR of 5.72% during the...

The respiratory care landscape is undergoing a massive shift as new medical breakthroughs redefine how we manage chronic lung conditions. With the Asthma Therapeutics Market Share being split between traditional inhalers and high-tech biologics, the industry is seeing a surge in patient-centric solutions. This evolution is not just about relieving symptoms but about fundamentally changing the...